[email protected]

USA: +1 347 690-0211 | UK: +44 2032 894158 | Translate : 

Search Market Research Report

Discover Our Latest Reports
Discover Our Featured Reports
Discover Top Selling Reports
  1. Home
  2. Biotechnology
  3. Next Generation Sequencing Market

Next Generation Sequencing Market Size, Share Global Analysis Report, 2020 – 2026

report img

Next Generation Sequencing Market By Application (Oncology, Clinical Investigation, Reproductive Health, Metagenomics, Epidemiology & Drug Development, Consumer Genomics, Agrigenomics & Forensics and HLA Typing/Immune System Monitoring) By Technology(Whole Genome Sequencing, Whole Exome Sequencing and Targeted Sequencing & Resequencing)By End Use(Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other users): Global Industry Perspective, Comprehensive Analysis, and Forecast 2020 – 2026

Industry Insights

[195+ Pages Report] According to the report published by Facts and Factors, the global Next Generation Sequencing market was valued at approximately USD 4,349.2 Million in 2019, and is expected to generate revenue of around USD 12,624.3 Million by end of 2026, growing at a CAGR of around 16.4% between 2020 and 2026.

Global Next Generation Sequencing Market Size

To know more about this report | Request Free Sample Copy

logoMarket Overview              

Next-generation sequencing technologies make it possible to sequence RNA and DNA in a reliable and cost-effective manner. These technologies are widely used in functional genomics to test DNA and RNA samples. The demand for next-generation sequencing will grow across all clinical applications. Next-generation sequencing (NGS) refers to large-scale DNA sequencing methods that assist in genome exploration. The term "next-generation sequencing," also known as "high-throughput sequencing," refers to a variety of modern sequencing technologies.

logoIndustry Growth Factors

Because of technical advances in NGS, an increase in NGS applications, and an increase in alliances and collaborations, the global next generation sequencing market is growing. Furthermore, the increase in genome mapping programs propels the global next generation sequencing market forward. However, concerns about standardization in NGS-based diagnostics, a shortage of qualified clinicians, and ethical and legal constraints are expected to stymie the market's growth. On the other hand, lucrative prospects in developing markets, as well as cloud computing as a future data management service, are expected to pay off handsomely for market participants.

logoSegmentation Analysis

The global next generation sequencing market is segregated based application, technology and end-use and regions. 

Oncology, clinical investigation, reproductive health, metagenomics, epidemiology & drug development, consumer genomics, agrigenomics & forensics and HLA typing/immune system monitoring are the application segment of global next generation sequencing market. In 2019, oncology brought in the most revenue, accounting for over 31.3% of total sales. The combination of next-generation sequencing (NGS) and bioinformatics tools has the ability to transform oncology discovery, diagnosis, and treatment. Advances in NGS technology have resulted in advancements in cancer science, signaling the start of cancer's "molecular era." The technology segment is categorized into whole genome sequencing, whole exome sequencing and targeted sequencing & resequencing. Moreover, the report is also categorized end use segment into academic research, clinical research, hospitals & clinics, pharma & biotech entities and other users

logo Regional Analysis

With a sales share of 47.85% in 2019, North America dominated the global market. The regional market is driven by the involvement of many clinical laboratories that use NGS to provide genetic testing services. In addition, main companies in North America are developing and launching new products, which is boosting business growth. For example, Quest Diagnostics launched the Automated NGS Engine in August 2020 to power AncestryHealth, Ancestry's consumer genetics offering. Genetic screening for blood disorders, bowel cancer, breast cancer, and heart disease is available via the platform.

logoReport Scope

Report Attribute

Details

Market Size in 2019

USD 4,349.2 Million

Projected Market Size in 2026

USD 12,624.3 Million

Growth Rate

CAGR 16.4%

Base Year

2019

Forecast Years

2020-2026

Key Market Players

Genomatix GmbH, PierianDx; DNASTAR, Inc., Eurofins GATC Biotech GmbH, Illumina, QIAGEN, Thermo Fisher Scientific, Inc., F. Hoffman-La Roche Ltd., Oxford Nanopore Technologies, Perkin Elmer, Inc., Bio-Rad Laboratories, Inc. and BGI amongst others.

Key Segment

By Application, By Technology, By End Use

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

Due to increased technological advances and funding provided by the government and private organizations, Asia-Pacific is expected to have the highest CAGR during the forecast era. Furthermore, increased investment by biotechnology and pharmaceutical companies is expected to boost consumer demand.

logo Competitive Players

Some main participants of the Next Generation Sequencing market are

  • Genomatix GmbH
  • PierianDx; DNASTAR Inc.
  • Eurofins GATC Biotech GmbH
  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • F. Hoffman-La Roche Ltd.
  • Oxford Nanopore Technologies
  • Perkin Elmer Inc.
  • Bio-Rad Laboratories In
  •  BGI

The global Next Generation Sequencing market is segmented as follows:

logoBy Application:

  • Oncology
  • Clinical Investigation
  • Reproductive Health
  • Metagenomics
  • Epidemiology & Drug Development
  • Consumer Genomics
  • Agrigenomics & Forensics
  • HLA Typing/Immune System Monitoring

logoBy Technology:

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing & Resequencing

logoBy End Use:

  • Academic Research
  • Clinical Research
  •  Hospitals & Clinics
  • Pharma & Biotech Entities
  • Other users

Table of Content

Chapter 1 Executive Summary
1.1. Introduction of Next Generation Sequencing (NGS)
1.2. Global Next Generation Sequencing (NGS) Market, 2019 & 2026 (USD Million)
1.3. Global Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
1.4. Global Next Generation Sequencing (NGS) Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
1.5. Global Next Generation Sequencing (NGS) Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
1.6. COVID-19 Impacts on Next Generation Sequencing Market
1.6.1. COVID-19 Impact on the Players
1.6.2. Business Strategies and Recommendations
Chapter 2 Next Generation Sequencing (NGS) Market – Application Analysis
2.1. Global Next Generation Sequencing (NGS) Market – Application Overview
2.2. Global Next Generation Sequencing (NGS) Market Share, by Application, 2019 & 2026 (USD Million)
2.3. Oncology
2.3.1. Global Oncology Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
2.4. Clinical Investigation
2.4.1. Global Clinical Investigation Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
2.5. Reproductive Health
2.5.1. Global Reproductive Health Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
2.6. Metagenomics, Epidemiology & Drug Development
2.6.1. Global Metagenomics, Epidemiology & Drug Development Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
2.7. HLA Typing/Immune System Monitoring
2.7.1. Global HLA Typing/Immune System Monitoring Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
2.8. Consumer Genomics
2.8.1. Global Consumer Genomics Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
2.9. Agrigenomics & Forensics
2.9.1. Global Agrigenomics & Forensics Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Chapter 3 Next Generation Sequencing (NGS) Market – Technology Analysis
3.1. Global Next Generation Sequencing (NGS) Market – Technology Overview
3.2. Global Next Generation Sequencing (NGS) Market Share, by Technology, 2019 & 2026 (USD Million)
3.3. Whole Genome Sequencing
3.3.1. Global Whole Genome Sequencing Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
3.4. Whole Exome Sequencing
3.4.1. Global Whole Exome Sequencing Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
3.5. Targeted Sequencing & Resequencing
3.5.1. Global Targeted Sequencing & Resequencing Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Chapter 4 Next Generation Sequencing (NGS) Market – End-Use Analysis
4.1. Global Next Generation Sequencing (NGS) Market – End-Use Overview
4.2. Global Next Generation Sequencing (NGS) Market Share, by End-Use, 2019 & 2026 (USD Million)
4.3. Academic Research
4.3.1. Global Academic Research Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
4.4. Clinical Research
4.4.1. Global Clinical Research Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
4.5. Hospitals & Clinics
4.5.1. Global Hospitals & Clinics Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
4.6. Pharma & Biotech Entities
4.6.1. Global Pharma & Biotech Entities Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
4.7. Other users
4.7.1. Global Other users Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Chapter 5 Next Generation Sequencing (NGS) Market – Regional Analysis
5.1. Global Next Generation Sequencing (NGS) Market Regional Overview
5.2. Global Next Generation Sequencing (NGS) Market Share, by Region, 2019 & 2026 (USD Million)
5.3. North America
5.3.1. North America Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.3.1.1. North America Next Generation Sequencing (NGS) Market, by Country, 2016 - 2026 (USD Million)
5.3.2. North America Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026
5.3.2.1. North America Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
5.3.3. North America Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026
5.3.3.1. North America Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
5.3.4. North America Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026
5.3.4.1. North America Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
5.3.5.  U.S.
5.3.5.1.   U.S. Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.3.6. Canada
5.3.6.1. Canada Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.4. Europe
5.4.1. Europe Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.4.1.1. Europe Next Generation Sequencing (NGS) Market, by Country, 2016 - 2026 (USD Million)
5.4.2. Europe Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026
5.4.2.1. Europe Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
5.4.3. Europe Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026
5.4.3.1. Europe Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
5.4.4. Europe Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026
5.4.4.1. Europe Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
5.4.5. Germany
5.4.5.1. Germany Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.4.6. France
5.4.6.1. France Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.4.7.   U.K.
5.4.7.1.  U.K. Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.4.8. Italy
5.4.8.1. Italy Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.4.9. Spain
5.4.9.1. Spain Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.4.10. Rest of Europe
5.4.10.1. Rest of Europe Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.5. Asia Pacific
5.5.1. Asia Pacific Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.5.1.1. Asia Pacific Next Generation Sequencing (NGS) Market, by Country, 2016 - 2026 (USD Million)
5.5.2. Asia Pacific Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026
5.5.2.1. Asia Pacific Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
5.5.3. Asia Pacific Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026
5.5.3.1. Asia Pacific Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
5.5.4. Asia Pacific Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026
5.5.4.1. Asia Pacific Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
5.5.5. China
5.5.5.1. China Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.5.6. Japan
5.5.6.1. Japan Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.5.7. India
5.5.7.1. India Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.5.8. South  Korea
5.5.8.1. South  Korea Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.5.9. South-East Asia
5.5.9.1. South-East Asia Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.5.10. Rest of Asia Pacific
5.5.10.1. Rest of Asia Pacific Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.6. Latin America
5.6.1. Latin America Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.6.1.1. Latin America Next Generation Sequencing (NGS) Market, by Country, 2016 - 2026 (USD Million)
5.6.2. Latin America Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026
5.6.2.1. Latin America Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
5.6.3. Latin America Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026
5.6.3.1. Latin America Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
5.6.4. Latin America Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026
5.6.4.1. Latin America Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
5.6.5. Brazil
5.6.5.1. Brazil Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.6.6. Mexico
5.6.6.1. Mexico Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.6.7. Rest of Latin America
5.6.7.1. Rest of Latin America Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.7. The Middle-East and Africa
5.7.1. The Middle-East and Africa Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.7.1.1. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Country, 2016 - 2026 (USD Million)
5.7.2. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026
5.7.2.1. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
5.7.3. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026
5.7.3.1. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
5.7.4. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026
5.7.4.1. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
5.7.5. GCC Countries
5.7.5.1. GCC Countries Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.7.6. South Africa
5.7.6.1. South Africa Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
5.7.7. Rest of Middle-East Africa
5.7.7.1. Rest of Middle-East Africa Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Chapter 6 Next Generation Sequencing (NGS) Market – Competitive Landscape
6.1. Competitor Market Share – Revenue
6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
6.3. Strategic Developments
6.3.1. Acquisitions and Mergers
6.3.2. New Products
6.3.3. Research & Development Activities
Chapter 7 Company Profiles
7.1. Genomatix GmbH
7.1.1. Company Overview
7.1.2. Product/Service Portfolio
7.1.3. Genomatix GmbH Sales, Revenue, and Gross Margin
7.1.4. Genomatix GmbH Revenue and Growth Rate
7.1.5. Genomatix GmbH Market Share
7.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
7.2. PierianDx
7.2.1. Company Overview
7.2.2. Product/Service Portfolio
7.2.3. PierianDx Sales, Revenue, and Gross Margin
7.2.4. PierianDx Revenue and Growth Rate
7.2.5. PierianDx Market Share
7.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
7.3. DNASTAR, Inc.
7.3.1. Company Overview
7.3.2. Product/Service Portfolio
7.3.3. DNASTAR, Inc. Sales, Revenue, and Gross Margin
7.3.4. DNASTAR, Inc. Revenue and Growth Rate
7.3.5. DNASTAR, Inc. Market Share
7.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
7.4. Illumina
7.4.1. Company Overview
7.4.2. Product/Service Portfolio
7.4.3. Illumina Sales, Revenue, and Gross Margin
7.4.4. Illumina Revenue and Growth Rate
7.4.5. Illumina Market Share
7.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
7.5. QIAGEN
7.5.1. Company Overview
7.5.2. Product/Service Portfolio
7.5.3. QIAGEN Sales, Revenue, and Gross Margin
7.5.4. QIAGEN Revenue and Growth Rate
7.5.5. QIAGEN Market Share
7.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
7.6. Thermo Fisher Scientific, Inc.
7.6.1. Company Overview
7.6.2. Product/Service Portfolio
7.6.3. Thermo Fisher Scientific, Inc. Sales, Revenue, and Gross Margin
7.6.4. Thermo Fisher Scientific, Inc. Revenue and Growth Rate
7.6.5. Thermo Fisher Scientific, Inc. Market Share
7.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
7.7. F. Hoffman-La Roche Ltd.
7.7.1. Company Overview
7.7.2. Product/Service Portfolio
7.7.3. F. Hoffman-La Roche Ltd. Sales, Revenue, and Gross Margin
7.7.4. F. Hoffman-La Roche Ltd. Revenue and Growth Rate
7.7.5. F. Hoffman-La Roche Ltd. Market Share
7.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
7.8. Oxford Nanopore Technologies
7.8.1. Company Overview
7.8.2. Product/Service Portfolio
7.8.3. Oxford Nanopore Technologies Sales, Revenue, and Gross Margin
7.8.4. Oxford Nanopore Technologies Revenue and Growth Rate
7.8.5. Oxford Nanopore Technologies Market Share
7.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
7.9. Eurofins GATC Biotech GmbH
7.9.1. Company Overview
7.9.2. Product/Service Portfolio
7.9.3. Eurofins GATC Biotech GmbH Sales, Revenue, and Gross Margin
7.9.4. Eurofins GATC Biotech GmbH Revenue and Growth Rate
7.9.5. Eurofins GATC Biotech GmbH Market Share
7.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
7.10. Perkin Elmer, Inc.
7.10.1. Company Overview
7.10.2. Product/Service Portfolio
7.10.3. Perkin Elmer, Inc. Sales, Revenue, and Gross Margin
7.10.4. Perkin Elmer, Inc. Revenue and Growth Rate
7.10.5. Perkin Elmer, Inc. Market Share
7.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
7.11. BGI
7.11.1. Company Overview
7.11.2. Product/Service Portfolio
7.11.3. BGI Sales, Revenue, and Gross Margin
7.11.4. BGI Revenue and Growth Rate
7.11.5. BGI Market Share
7.11.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
7.12. Bio-Rad Laboratories, Inc.
7.12.1. Company Overview
7.12.2. Product/Service Portfolio
7.12.3. Bio-Rad Laboratories, Inc. Sales, Revenue, and Gross Margin
7.12.4. Bio-Rad Laboratories, Inc. Revenue and Growth Rate
7.12.5. Bio-Rad Laboratories, Inc. Market Share
7.12.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
Chapter 8 Next Generation Sequencing (NGS) — Industry Analysis
8.1. Introduction and Taxonomy
8.2. Next Generation Sequencing (NGS) Market – Key Trends
8.2.1. Market Drivers
8.2.2. Market Restraints
8.2.3. Market Opportunities
8.3. Value Chain Analysis
8.4. Key Mandates and Regulations
8.5. Porter’s Five Forces Model
8.5.1. Bargaining Power of Buyers
8.5.2. Bargaining Power of Suppliers
8.5.3. Threat of Substitute
8.5.4. Threat of New Entrants
8.5.5. Rivalry among Existing Competitors
8.6. PESTEL Analysis
8.7. SWOT Analysis
8.8. Technology Roadmap and Timeline
8.9. Next Generation Sequencing (NGS) Market – Attractiveness Analysis
8.9.1. By Application
8.9.2. By Technology
8.9.3. By End-Use
8.9.4. By Region
Chapter 9 Report Conclusion & Key Insights
9.1. Key Insights from Primary Interviews & Surveys Respondents
9.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
Chapter 10 Research Approach & Methodology
10.1. Report Description
10.2. Research Scope
10.3. Research Methodology
10.3.1. Secondary Research
10.3.2. Primary Research
10.3.3. Statistical Models
10.3.3.1. Company Share Analysis Model
10.3.3.2. Revenue Based Modeling
10.3.4. Research Limitations

List of Figures

Fig.1	Product Picture of Next Generation Sequencing (NGS)
Fig.2	Global Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.3	Global Next Generation Sequencing (NGS) Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
Fig.4	Global Next Generation Sequencing (NGS) Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
Fig.5	COVID-19 Impacts on Next Generation Sequencing Market
Fig.6	COVID-19 Impact on the Players
Fig.7	Business Strategies and Recommendations
Fig.8	Global Next Generation Sequencing (NGS) Market Share, by Application, 2019 & 2026 (USD Million)
Fig.9	Global Oncology Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.10	Global Clinical Investigation Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.11	Global Reproductive Health Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.12	Global Metagenomics, Epidemiology & Drug Development Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.13	Global HLA Typing/Immune System Monitoring Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.14	Global Consumer Genomics Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.15	Global Agrigenomics & Forensics Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.16	Global Next Generation Sequencing (NGS) Market Share, by Technology, 2019 & 2026 (USD Million)
Fig.17	Global Whole Genome Sequencing Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.18	Global Whole Exome Sequencing Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.19	Global Targeted Sequencing & Resequencing Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.20	Global Next Generation Sequencing (NGS) Market Share, by End-Use, 2019 & 2026 (USD Million)
Fig.21	Global Academic Research Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.22	Global Clinical Research Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.23	Global Hospitals & Clinics Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.24	Global Pharma & Biotech Entities Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.25	Global Other users Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.26	Global Next Generation Sequencing (NGS) Market Share, by Region, 2019 & 2026 (USD Million)
Fig.27	North America Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.28	U.S. Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.29	Canada Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.30	Europe Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.31	Germany Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.32	France Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.33	U.K. Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.34	Italy Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.35	Spain Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.36	Rest of Europe Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.37	Asia Pacific Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.38	China Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.39	Japan Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.40	India Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.41	South  Korea Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.42	South-East Asia Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.43	Rest of Asia Pacific Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.44	Latin America Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.45	Brazil Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.46	Mexico Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.47	Rest of Latin America Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.48	The Middle-East and Africa Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.49	GCC Countries Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.50	South Africa Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.51	Rest of Middle-East Africa Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
Fig.52	Competitor Market Share – Revenue
Fig.53	Genomatix GmbH Revenue and Growth Rate
Fig.54	Genomatix GmbH Market Share
Fig.55	PierianDx Revenue and Growth Rate
Fig.56	PierianDx Market Share
Fig.57	DNASTAR, Inc. Revenue and Growth Rate
Fig.58	DNASTAR, Inc. Market Share
Fig.59	Illumina Revenue and Growth Rate
Fig.60	Illumina Market Share
Fig.61	QIAGEN Revenue and Growth Rate
Fig.62	QIAGEN Market Share
Fig.63	Thermo Fisher Scientific, Inc. Revenue and Growth Rate
Fig.64	Thermo Fisher Scientific, Inc. Market Share
Fig.65	F. Hoffman-La Roche Ltd. Revenue and Growth Rate
Fig.66	F. Hoffman-La Roche Ltd. Market Share
Fig.67	Oxford Nanopore Technologies Revenue and Growth Rate
Fig.68	Oxford Nanopore Technologies Market Share
Fig.69	Eurofins GATC Biotech GmbH Revenue and Growth Rate
Fig.70	Eurofins GATC Biotech GmbH Market Share
Fig.71	Perkin Elmer, Inc. Revenue and Growth Rate
Fig.72	Perkin Elmer, Inc. Market Share
Fig.73	BGI Revenue and Growth Rate
Fig.74	BGI Market Share
Fig.75	Bio-Rad Laboratories, Inc. Revenue and Growth Rate
Fig.76	Bio-Rad Laboratories, Inc. Market Share
Fig.77	Market Dynamics
Fig.78	Global Next Generation Sequencing (NGS) – Value Chain Analysis
Fig.79	Key Mandates and Regulations
Fig.80	PESTEL Analysis
Fig.81	SWOT Analysis
Fig.82	Technology Roadmap and Timeline
Fig.83	Market Attractiveness Analysis – By Application
Fig.84	Market Attractiveness Analysis – By Technology
Fig.85	Market Attractiveness Analysis – By End-Use
Fig.86	Market Attractiveness Analysis – By Region

List of Tables

Table 1	Global Next Generation Sequencing (NGS) Market, 2019 & 2026 (USD Million)
Table 2	Global Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
Table 3	Global Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
Table 4	Global Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
Table 5	Global Next Generation Sequencing (NGS) Market, by Region, 2016 – 2026 (USD Million)
Table 6	North America Next Generation Sequencing (NGS) Market, by Country, 2016 – 2026 (USD Million)
Table 7	North America Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
Table 8	North America Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
Table 9	North America Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
Table 10 Europe Next Generation Sequencing (NGS) Market, by Country, 2016 – 2026 (USD Million)
Table 11 Europe Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
Table 12 Europe Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
Table 13 Europe Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
Table 14 Asia Pacific Next Generation Sequencing (NGS) Market, by Country, 2016 – 2026 (USD Million)
Table 15 Asia Pacific Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
Table 16 Asia Pacific Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
Table 17 Asia Pacific Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
Table 18 Latin America Next Generation Sequencing (NGS) Market, by Country, 2016 – 2026 (USD Million)
Table 19 Latin America Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
Table 20 Latin America Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
Table 21 Latin America Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
Table 22 The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Country, 2016 – 2026 (USD Million)
Table 23 The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
Table 24 The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
Table 25 The Middle-East and Africa Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
Table 26 Global Next Generation Sequencing (NGS) Market - Company Revenue Analysis, 2016 – 2019 (USD Million)
Table 27 Global Next Generation Sequencing (NGS) Market - Company Revenue Share Analysis, 2016 – 2019 (%)
Table 28 Acquisitions and Mergers
Table 29 Market Drivers – Impact Analysis
Table 30 Market Restraints
Table 31 Market Opportunities

 

Industry Major Market Players

  • Genomatix GmbH
  • PierianDxDNASTAR Inc.
  • Eurofins GATC Biotech GmbH
  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • F. Hoffman-La Roche Ltd.
  • Oxford Nanopore Technologies
  • Perkin Elmer Inc.
  • Bio-Rad Laboratories Inc.
  • BGI

paypal
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors